Nuntra Suwantarat1, Latania K Logan2, Karen C Carroll1, Robert A Bonomo3, Patricia J Simner1, Susan D Rudin4, Aaron M Milstone5, Tsigereda Tekle1, Tracy Ross1, Pranita D Tamma5. 1. 1Division of Medical Microbiology,Johns Hopkins Medical Institutions,Baltimore,Maryland,USA. 2. 3Section of Pediatric Infectious Diseases,Rush University Medical Center,Chicago,Illinois,USA. 3. 4Louis Stokes Cleveland Department of Veterans' Affairs Medical Center,Cleveland,Ohio,USA. 4. 6Department of Molecular Biology and Microbiology,Case Western Reserve University School of Medicine,Cleveland,Ohio,USA. 5. 8Division of Pediatric Infectious Diseases,Johns Hopkins University School of Medicine,Baltimore,Maryland,USA.
Abstract
OBJECTIVE: To determine the prevalence and acquisition of extended-spectrum β-lactamases (ESBLs), plasmid-mediated AmpCs (pAmpCs), and carbapenemases ("MDR Enterobacteriaceae") colonizing children admitted to a pediatric intensive care unit (PICU). DESIGN: Prospective study. SETTING: 40-bed PICU. METHODS: Admission and weekly thereafter rectal surveillance swabs were collected on all pediatric patients during a 6-month study period. Routine phenotypic identification and antibiotic susceptibility testing were performed. Enterobacteriaceae displaying characteristic resistance profiles underwent further molecular characterization to identify genetic determinants of resistance likely to be transmitted on mobile genetic elements and to evaluate relatedness of strains including DNA microarray, multilocus sequence typing, repetitive sequence-based PCR, and hsp60 sequencing typing. RESULTS: Evaluating 854 swabs from unique children, the overall prevalence of colonization with an MDR Enterobacteriaceae upon admission to the PICU based on β-lactamase gene identification was 4.3% (n=37), including 2.8% ESBLs (n=24), 1.3% pAmpCs (n=11), and 0.2% carbapenemases (n=2). Among 157 pediatric patients contributing 603 subsequent weekly swabs, 6 children (3.8%) acquired an incident MDR Enterobacteriaceae during their PICU stay. One child acquired a pAmpC (E. coli containing bla DHA) related to an isolate from another patient. CONCLUSIONS: Approximately 4% of children admitted to a PICU were colonized with MDR Enterobacteriaceae (based on β-lactamase gene identification) and an additional 4% of children who remained in the PICU for at least 1 week acquired 1 of these organisms during their PICU stay. The acquired MDR Enterobacteriaceae were relatively heterogeneous, suggesting that a single source was not responsible for the introduction of these resistance mechanisms into the PICU setting.
OBJECTIVE: To determine the prevalence and acquisition of extended-spectrum β-lactamases (ESBLs), plasmid-mediated AmpCs (pAmpCs), and carbapenemases ("MDR Enterobacteriaceae") colonizing children admitted to a pediatric intensive care unit (PICU). DESIGN: Prospective study. SETTING: 40-bed PICU. METHODS: Admission and weekly thereafter rectal surveillance swabs were collected on all pediatric patients during a 6-month study period. Routine phenotypic identification and antibiotic susceptibility testing were performed. Enterobacteriaceae displaying characteristic resistance profiles underwent further molecular characterization to identify genetic determinants of resistance likely to be transmitted on mobile genetic elements and to evaluate relatedness of strains including DNA microarray, multilocus sequence typing, repetitive sequence-based PCR, and hsp60 sequencing typing. RESULTS: Evaluating 854 swabs from unique children, the overall prevalence of colonization with an MDR Enterobacteriaceae upon admission to the PICU based on β-lactamase gene identification was 4.3% (n=37), including 2.8% ESBLs (n=24), 1.3% pAmpCs (n=11), and 0.2% carbapenemases (n=2). Among 157 pediatric patients contributing 603 subsequent weekly swabs, 6 children (3.8%) acquired an incident MDR Enterobacteriaceae during their PICU stay. One child acquired a pAmpC (E. coli containing bla DHA) related to an isolate from another patient. CONCLUSIONS: Approximately 4% of children admitted to a PICU were colonized with MDR Enterobacteriaceae (based on β-lactamase gene identification) and an additional 4% of children who remained in the PICU for at least 1 week acquired 1 of these organisms during their PICU stay. The acquired MDR Enterobacteriaceae were relatively heterogeneous, suggesting that a single source was not responsible for the introduction of these resistance mechanisms into the PICU setting.
Authors: Jennifer H Han; Warren B Bilker; Irving Nachamkin; Theoklis E Zaoutis; Susan E Coffin; Darren R Linkin; Baofeng Hu; Pam Tolomeo; Neil O Fishman; Ebbing Lautenbach Journal: Infect Control Hosp Epidemiol Date: 2013-09-23 Impact factor: 3.254
Authors: Latania K Logan; John P Renschler; Sumanth Gandra; Robert A Weinstein; Ramanan Laxminarayan Journal: Emerg Infect Dis Date: 2015-11 Impact factor: 6.883
Authors: Michael Levy; Stéphane Bonacorsi; Jérôme Naudin; Marion Caseris; Eric Thebault; Patricia Mariani-Kurkdjian; Maryline Chomton; Julie Sommet; Stéphane Dauger; Catherine Doit Journal: Intensive Care Med Date: 2019-03-06 Impact factor: 17.440
Authors: David X Li; Anna C Sick-Samuels; Nuntra Suwantarat; Rebecca G Same; Patricia J Simner; Pranita D Tamma Journal: Infect Control Hosp Epidemiol Date: 2017-12-05 Impact factor: 3.254
Authors: Pranita D Tamma; Nuntra Suwantarat; Susan D Rudin; Latania K Logan; Patricia J Simner; Laura J Rojas; Maria F Mojica; Karen C Carroll; Robert A Bonomo Journal: J Pediatric Infect Dis Soc Date: 2016-05-04 Impact factor: 3.164
Authors: Kathleen Chiotos; Pranita D Tamma; Kelly B Flett; Matthew Naumann; Manjiree V Karandikar; Warren B Bilker; Theoklis Zaoutis; Jennifer H Han Journal: Antimicrob Agents Chemother Date: 2017-11-22 Impact factor: 5.191